Alon Y Hershko
Overview
Explore the profile of Alon Y Hershko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
396
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hershkowitz I, Moss J, Sosna J, Netser E, Cahn A, Hershko A
Isr Med Assoc J
. 2025 Feb;
27(1):42-48.
PMID: 39931005
Background: Management of patients with reported iodinated contrast media (ICM) allergy is not supported by sufficient data. It is assumed that these patients are at risk for severe reactions, and...
2.
Assaad A, Hershko A, Irani C, Mahdavinia M, Khan D, Bernstein J
J Allergy Clin Immunol Glob
. 2024 Nov;
4(1):100350.
PMID: 39559798
Health care disparities refer to differences in health and health care between groups that are closely associated with governmental, social, economic, and/or environmental policies. To address this gap in knowledge,...
3.
Hershkowitz I, Cahn A, Haran T, Hershko A
Isr Med Assoc J
. 2024 Feb;
26(1):54-55.
PMID: 38420645
No abstract available.
4.
Hershko A, Levi-Schaffer F
Ann Allergy Asthma Immunol
. 2024 Feb;
133(6):621-622.
PMID: 38412918
No abstract available.
5.
Ribak Y, Rubin L, Talmon A, Dranitzki Z, Shamriz O, Hershkowitz I, et al.
Front Immunol
. 2023 Sep;
14:1172896.
PMID: 37654487
Background: The mRNA-based COVID-19 vaccine was introduced to the general public in December 2020. Shortly thereafter, safety concerns were raised due to the reporting of allergic reactions. Allergy-related disorders were...
6.
Tal Y, Ribak Y, Rubin L, Talmon A, Shamriz O, Hershko A, et al.
J Allergy Clin Immunol Pract
. 2023 Jul;
11(10):3047-3054.
PMID: 37394178
Background: Epinephrine intramuscular (IM) autoinjector is a life-saving drug for the emergency treatment of immediate-type allergic reactions (type I). Nevertheless, it is sometimes applied incorrectly or underused because of short...
7.
Anis E, Preis S, Cedar N, Tal Y, Hershkowitz I, Hershko A
J Allergy Clin Immunol Pract
. 2022 Jul;
10(11):2969-2976.
PMID: 35872216
Background: In December 2020, the Israeli Ministry of Health launched a national vaccination campaign against SARS-CoV-2. Concomitant sporadic reports on anaphylactic responses in other countries raised safety concerns at the...
8.
Tal Y, Hershcovich I, Talmon A, Ribak Y, Shamriz O, Toker O, et al.
J Intern Med
. 2021 Oct;
291(3):377-379.
PMID: 34700358
No abstract available.
9.
Shamriz O, Hershko A, Talmon A, Ribak Y, Scheiman Elazary A, Horev L, et al.
Allergol Int
. 2021 Mar;
70(2):266-268.
PMID: 33779559
No abstract available.
10.
Rubin L, Shamriz O, Toker O, Kadish E, Ribak Y, Talmon A, et al.
J Asthma
. 2020 Dec;
59(3):476-483.
PMID: 33297810
Objective: Common variable immune deficiency (CVID) encompasses a variety of diseases characterized by disturbed immunoglobulin (Ig) production and various immune dysregulations. Scarce data are available regarding relationships between CVID and...